文献速递心力衰竭与心肌病

电子健康档案提醒对住院射血分数降低心衰患者管理的影响:PROMPT-AHF试验

Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial.
PubMed 文献 · Eur Heart J · 2023-01-01

出院时仅11.2%患者使用全部四类GDMT。

要点

  • 实时定制EHR提醒未提高急性心衰出院时总体GDMT处方数量。
  • 出院时仅11.2%患者使用全部四类GDMT,GDMT仍不理想。

核心结论

  • 针对急性心衰的实时、靶向、定制EHR提醒系统未导致出院时总体GDMT处方数量增加。
  • 需进一步改进此类提醒并改变临床医生激励措施以克服GDMT实施障碍。
  • 该场景下GDMT仍不理想,仅九分之一患者以全面循证方案出院。

研究设计与样本

  • PROMPT-AHF为务实、多中心、基于EHR的随机临床试验。
  • 患者入院48小时后若符合预设急性心衰住院标准则自动入组。
  • 干预组患者在医嘱录入时收到提醒,包含相关患者特征、个体化GDMT推荐及订单集链接。
  • 中位年龄74岁;26%为女性,24%为黑人。

主要发现

  • 提醒时85%患者使用β受体阻滞剂,55%使用ACEI/ARB/ARNI,20%使用MRA,17%使用SGLT2抑制剂。
  • 出院时11.2%患者使用全部四类GDMT。

临床怎么用

  • 不应仅依赖实时EHR提醒来提高急性心衰住院患者出院时总体GDMT处方率。
  • EHR提醒可能对特定药物类别(如MRA)的处方增加有促进作用。
  • 需结合其他策略(如临床医生激励措施改进)以克服GDMT实施障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients hospitalized for acute heart failure (AHF) continue to be discharged on an inadequate number of guideline-directed medical therapies (GDMT) despite evidence that inpatient initiation is beneficial. This study aimed to examine whether a tailored electronic health record (EHR) alert increased rates of GDMT prescription at discharge in eligible patients hospitalized for AHF. METHODS: Pragmatic trial of messaging to providers about treatment of acute heart failure (PROMPT-AHF) was a pragmatic, multicenter, EHR-based, and randomized clinical trial. Patients were automatically enrolled 48 h after admission if they met pre-specified criteria for an AHF hospitalization. Providers of patients in the intervention arm received an alert during order entry with relevant patient characteristics along with individualized GDMT recommendations with links to an order set. The primary outcome was an increase in the number of GDMT prescriptions at discharge. RESULTS: Thousand and twelve patients were enrolled between May 2021 and November 2022. The median age was 74 years; 26% were female, and 24% were Black. At the time of the alert, 85% of patients were on β-blockers, 55% on angiotensin-converting enzyme inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor, 20% on mineralocorticoid receptor antagonist (MRA) and 17% on sodium-glucose cotransporter 2 inhibitor. The primary outcome occurred in 34% of both the alert and no alert groups [adjusted risk ratio (RR): 0.95 (0.81, 1.12), P = .99]. Patients randomized to the alert arm were more likely to have an increase in MRA [adjusted RR: 1.54 (1.10, 2.16), P = .01]. At the time of discharge, 11.2% of patients were on all four pillars of GDMT. CONCLUSIONS: A real-time, targeted, and tailored EHR-based alert system for AHF did not lead to a higher number of overall GDMT prescriptions at discharge. Further refinement and improvement of such alerts and changes to clinician incentives are needed to overcome barriers to the implementation of GDMT during hospitalizations for AHF. GDMT remains suboptimal in this setting, with only one in nine patients being discharged on a comprehensive evidence-based regimen for heart failure.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Ghazi, Yamamoto, Fuery, et al. Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial. Eur Heart J. 2023. PMID: 37650264. doi:10.1093/eurheartj/ehad512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。